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Lophatheri Herba (Danzhuye; LH), the dried leaves of Lophatherum gracile Brongn (Poaceae),
is commonly used in Chinese herbal medicine as an antipyretic, antibacterial, and diuretic.
Chemical analysis has been conducted to isolate and identify seven major flavonoid gly-
cosides, including a new flavone C-glycoside, luteolin 6-C-b-D-glucuronopyranosyl-(1/2)-
b-D-glucopyranoside (1), isoorientin (2), swertiajaponin (3), luteolin 6-C-b-D-glucur-
onopyranosyl-(1/2)-a-L-arabinopyranoside (4), isovitexin (5), swertisin (6), luteolin 7-O-b-
D-glucopyranoside (7), and luteolin 6-C-a-L-arabinopyranoside (8), from commercially
available LHs in Taiwan. The structure of the new compound (1), the maximum compo-
nent, was determined by extensive one- (1D-) and two-dimensional (2D-) nuclear magnetic
resonance (NMR), and MS spectral analyses. The 1H and 13C-NMR of two rotameric pairs of
3 and 6 were also assigned. To establish the quality control platform of LH, we developed a
simultaneous determination of multiple components in 10 commercially available LHs,
collected from different areas of Taiwan, by high performance liquid chromatography
(HPLC) and ultra performance liquid chromatography (UPLC), as well as quantitative
measurement of the major components 1e4, and 8. All isolated major compounds
showed good linear regression (R2  0.9993) within the test ranges and high
reproducibility. These methods are readily accessible for the quality control of LH.
Copyright © 2015, Food and Drug Administration, Taiwan. Published by Elsevier Taiwan
LLC.
 
Open access under CC BY-NC-ND license.1. Introduction
Lophatheri Herba (Danzhuye; LH), the dried leaves of Lopha-
therum gracile Brongn (Poaceae), is a widely used Chinesestitute of Chinese Medici
. Lin).
ministration, Taiwan. Publherbal medicine as an antipyretic, antibacterial, and diuretic,
etc., for treating fever and urinary tract inflammation [1].
Commercially available LHs in Taiwan are all imported from
mainland China. The flavonoids, triterpenes, phenolic acids,
etc., have been isolated from LH, of which triterpenes andne, Number 155e1, Section 2, Linong Street, Beitou District, Taipei
ished by Elsevier Taiwan LLC. Open access under CC BY-NC-ND license.
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its main and active components [2e4], although the simulta-
neous determination of flavonoid glycosides in LH has also
been reported [4e6]. However, in addition to isoorientin, their
chemical markers are different from each other.
The Chinese Pharmacopoeia (2010) uses macroscopic
characteristics and tissue features as the quality control of the
medical material [7]. In addition to tissue microscopic identi-
fication, isoorientin (luteolin 6-C-b-D-glucopyranoside) was
used as a chemical marker for thin layer chromatography
(TLC) and HPLC chromatographic standard in Hong Kong
Chinese Materia Medica (HKCMM) Standards (2012) [8]. How-
ever, we found that isoorientin is not the maximum compo-
nent in commercially available LHs of Taiwan. To set up the
quality control platform, in addition to macro- and micro-
scopic authentication, we performed the chemical isolation of
the major flavonoid glycosides in LH and developed their
simultaneous determination by HPLC and UPLC, as well as
quantitation of the major components.2. Materials and methods
2.1. General
The infrared (IR) spectra were recorded on a Nicolet Avatar
320 Fourier transform IR spectrophotometer (Thermo Elec-
tron, Akron, OH, USA). The UV spectra were measured on a
Hitachi U-3310 spectrophotometer (Hitachi High Technolo-
gies America, Salt Lake City, UT, USA). The NMR spectra were
run on a Varian unity INOVA-500, and Varian VNMRS 600
spectrometers (Palo Alto, CA, USA). The Electrospray ioniza-
tion (ESI) and High-resolution electrospray ionisation (HR-
ESI) mass spectra were recorded on a Finnigan MAT LCQ ion
trap mass spectrometer and a Finnigan MAT 95S mass
spectrometer (Finnigan MAT, San Jose, CA, USA), respec-
tively. The HPLC analyses and UPLC were run on a Hitachi L-
7100 pump equipped with a binary solvent delivery and
autosampler (Hitachi, Tokyo, Japan), and a Waters Acquity
Ultra Performance LC (Waters, Milford, MA, USA), respec-
tively. Column chromatography was performed using silica
gel (70e230 mesh, Merck, Darmstadt, Germany) and Sepha-
dex LH-20 (Amersham Biosciences, Uppsala, Sweden). Iso-
orientin and quercitrin (quercetin 3-O-a-L-rhamnoside) (as
internal standard; I.S.) were bought from Tauto Biotech
(Shanghai, China). Solvents were purchased from Merck
(Darmstadt, Germany).
2.2. Herbal materials
The dried LHs were obtained from local retailers and taxo-
nomically authenticated by I-Jung Lee, Ph.D., a curator of the
Herbarium of National Research Institute of Chinese Medicine
(NRICM), Taipei, Taiwan, and deposited in the Herbarium of
NRICM (NHP 00317).
2.3. Extraction and isolation
The air dried LHs (3 kg) were extracted with 80% EtOH at 50C
overnight twice. The extract solution was concentrated undera vacuum to yield a residue (335 g, 11.2% of dried herbal ma-
terials), which was partitioned with EtOAc and H2O, to give
EtOAc-soluble (71.0 g, 2.37% of dried herbal materials), and
H2O-soluble fractions (256 g, 8.53% of dried herbal materials).
A part of the H2O-soluble fraction (200 g) was conducted Dia-
ion HP-20 column chromatography (CC, 12.0 cm  65 cm) with
an MeOH/H2O gradient to give the flavonoid enriched frac-
tions, 50%MeOH, 60e70%MeOH-, andMeOH eluates. The 50%
MeOH eluate was further purified over a Sephadex LH-20 CC
(60%MeOH), and preparative HPLC to give a new compound (1)
(1.95 g) and 4 (14.5mg). The 60e70%MeOHeluate of DiaionHP-
20 CC was re-chromatogramed on Sephadex LH-20 CC with
75% MeOH/H2O elution to yield 2 (1.46 g) and 3 (2.13 g). The
MeOH eluatewas separated by Sephadex LH-20 CCwithMeOH
elution to yield 5 (7.8 mg), 6 (6.8 mg), 7 (11.2 mg), and 8
(78.6 mg). Each known compound was confirmed by ESI-MS,
1H NMR, and 13C NMR spectrum analyses, and then
compared with the published data (Fig. 1).
2.3.1. Luteolin 6-C-b-D-glucuronopyranosyl-(1/2)-b-D-
glucopyranoside (1)
Yellow amorphous powder; mp 244e248 C (dec.); ESI-MSm/z
623 [M-H]-; HR-ESI-MS m/z: 623.1243 [M-H]- (calcd. for
C27H27O17: 623.1247); IR (KBr): ymax 3416 cm
1, 1650 cm1,
1618 cm1, 1491 cm1, 1197 cm1, 1180 cm1, 1115 cm1,
1078 cm1; UV (MeOH) lmax: 349 nm, 271 nm, 255 nm, 210 nm;
1H NMR (DMSO-d6, 500 MHz) d 2.62 (1H, t, J¼ 8.5 Hz, H-2000), 2.93
(1H, t, J ¼ 9.0 Hz, H-4000), 3.03 (1H, t, J ¼ 8.5 Hz, H-3000), 3.12 (1H, t,
J¼ 9.6 Hz, H-400), 3.13 (1H, m, H-5000), 3.15 (1H,m, H-500), 3.37 (1H,
dd, J ¼ 12.0, 5.1 Hz, H-600), 3.39 (1H, t, J ¼ 9.6 Hz, H-300), 3.65 (1H,
dd, J¼ 12.0, 2.1 Hz, H-600), 4.48 (1H, d, J¼ 8.0 Hz, H-1000), 4.59 (1H,
d, J¼ 9.6 Hz, H-100), 4.85 (1H, t, J¼ 9.6 Hz, H-200), 6.32 (1H, s, H-8),
6.64 (1H, s, H-3), 6.86 (1H, d, J ¼ 8.0 Hz, H-50), 7.41 (1H, dd,
J ¼ 8.0, 2.1 Hz, H-60), 7.41 (1H, d, J¼ 2.1 Hz, H-20), 13.52 (1H, br s,
OH); 13C NMR (DMSO-d6, 125 MHz) d 61.6 (t, C-600), 71.2 (d, C-400),
71.3 (d, C-100), 72.4 (d, C-4000), 73.1 (d, C-5000), 73.8 (d, C-2000), 75.0 (d,
C-200), 76.8 (d, C-3000), 79.4 (d, C-300), 82.1 (d, C-500), 97.6 (d, C-8),
102.4 (d, C-3), 102.8 (s, C-10), 103.3 (d, C-1000), 110.0 (s, C-6), 113.0
(C-20), 116.1 (d, C-50), 118.7 (d, C-60), 121.4 (s, C-10), 145.7 (s, C-
30), 149.7 (s, C-40), 155.8 (s, C-9), 160.4 (s, C-5), 163.4 (s, C-2),
166.9 (s, C-7), 174.4 (s, C-6000), 181.7 (s, C-4); 2D H-H Correlation
Spectroscopy (COSY) and 1D Total Correlation Spectroscopy
(TOCSY) indicated the correlations of two glycosidic moieties:
d 4.59 (d)/ d 4.85 (t)/ d 3.39 (t)/ d 3.12 (t)/ d 3.15 (m)/ d
3.37 (dd) and d 3.65 (dd); and d 4.48 (d) / d 2.62 (t) / d 3.03
(t) / d 2.93 (t) / d3.13 (d); Heteronuclear Multiple Bond
Correlation (HMBC) correlations are shown in Fig. 2.
2.4. HPLC and UPLC chromatographic conditions
The HPLC analyses were run over an Ascentis C18 column
(5 mm, 4.6 mm  250 mm; Supelco Analytical, Bellefonte, PA,
USA) with a mobile phase: A: 1.0% acetic acid, B: acetonitrile
and using a program of 90% A in 0e3 minutes, 90e87% of A in
3e5 minutes, 87e83% of A in 5e25 minutes, 83e80% of A in
25e50 minutes, 80e0% of A in 50e55 minutes, 0e90% of A in
55e58 minutes, and 90% of A in 58e60 minutes. Solvent flow
rate was 1.0 mL/minute. Injection volume was 20 mL and
detected at 350 nm. UPLC analyses were performed over a
Waters Acquity UPLC Bech C18, 1.7 mm column with a
Fig. 1 e Structures of flavonoid glycosides isolated from Lophatheri Herba.
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87% A in 3e9 minutes, 87e84% A in 9e12 minutes, 84% A in
12e18 minutes, set flow rate at 0.4 mL/minute, injected 2 ml,
column temperature at 35C, and recorded at 350 nm.2.5. Sample preparation
For HPLC analysis, each 0.5 g of 20 mesh of powdered
commercially available LH in 10 mL of 30% EtOH/H2O wasFig. 2 e Key HMBC correlations of 1.sonicated (40 kHz) twice for 30 minutes at room temperature.
Themixture of each extract was centrifuged at 5000 rpm for 10
minutes. The obtained supernatants was constituted into
20 mL and filtered through a syringe filter (0.22 mm). Aliquots
(20 mL) of resultant extract directly conducted HPLC analysis.
For standard compounds and quercetrin (I.S.), 2000 ppm of
each compound was prepared as a stock solution.2.6. Calibration curves
The stock solutions of compounds 1e4, 8, and I.S. were diluted
with aqueous methanol to the appropriate concentration
ranges. Each calibration curve was performed with five
different concentrations in triplicate. The calibration curves
were constructed by plotting a peak area versus concentration
for each analyte. Linear regression analysis for each com-
pound was conducted by the external standard method.2.7. Limit of detection and limit of quantitation
Using the same as the above analytical method by injecting
a series of dilution of standard compounds in triplicate, the
limit of detection for each compound was determined at the
ratio of a peak area of the signal to noise 3:1. For the limit
of quantitation, the signal to noise ratio 10:1 was
determined.
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Intraday and interday variability and reproducibility were used
to evaluate theprecisionandaccuracyof theanalyticalmethod.
Aliquots of quantitated standard analytes (high, middle, and
low concentrations in the range of the corresponding calibra-
tion curve) and I.S. were prepared and analyzed as the above
method in triplicate to determine the intraday variability. The
interday reproducibility was similarly performed over 3 sepa-
rate days. An acceptable relative standard deviation (RSD)
within 5% was taken as a measurement of stability (precision)
and reproducibility (accuracy) for the HPLC analysis.3. Results and discussion
3.1. Tissue characteristics and structural analysis of
isolated authentic compounds
Ten commercially available LHs were collected from different
areas of Taiwan. The macroscopic and microscopic authen-
tication showed that there were no significant differences
between them. For chemical analysis, the aqueous ethanolic
extract of LH was partitioned between EtOAc and H2O, to give
EtOAc and H2O fractions. The H2O extract was subjected to
Diaion HP-20 and Sephadex LH-20 CC, as well as reverse phase
preparative HPLC, to give eight flavonoid glycosides (1e8).
Among them, compound 1was identified as a new compound
and the maximum component in most of the LHs. The other
compounds were identified as isoorientin (2) [2,9], swertiaja-
ponin (3) [2,9], luteolin 6-C-b-D-glucuronopyranosyl-(1/2)-a-
L-arabinopyranoside (4) [3], isovitexin (5) [2], swertisin (6) [8],
luteolin 7-O-b-D-glucopyranoside (7) [10], and luteolin 6-C-a-
L-arabinopyranoside (8) [8] (Fig. 1). The flavonoid glycoside
profiles were developed by HPLC and UPLC (Fig. 3). The con-
tents of major components 1e4 and 8 in commercially avail-
able LHs were determined by HPLC.
3.2. Structural elucidation of new compound (1)
Compound 1 was isolated as yellow amorphous powder [mp
244e248C (dec.)]. The molecular formula was established as
C27H28O17 on the basis of a negative HR-ESI-MS which showed
a quasi-molecular ion peak at m/z 623.1243 [M-H]- (calcd. for
C27H27O17: 623.1247).
1H and 13C NMR data were similar to
those of luteolin 6-C-glucopyranoside (isoorientin) with the
exception of one more glycosyl moiety [11]. The 1H NMR
showed two anomeric protons at dH 4.48 (d, J¼ 8.0 Hz) and 4.59
(d, J ¼ 10.0 Hz), which indicated that the presence of two b-
configuration of sugars and one of the glycosyl moieties are
directly connected to carbon. The COSY and 1DTOCSY spectra
indicated that the two sets of sugarmoieties are dH 4.59/ 4.85
/ 3.39 / 3.12 / 3.15 / 3.37, and 3.65, and dH
4.48/ 2.62/ 3.03/ 2.93/ 3.13 (J ¼ 10.2 Hz), respectively.
The 13C NMR signals at dC 71.3 (d), 75.0 (d), 79.4 (d), 71.2 (d), 82.1
(d), 61.6 (t), and 103.3 (d), 73.8 (d), 76.8 (d), 72.4 (d), 73.1 (d), and
174.4 (s), indicated the presence of a glucopyranosyl, and a
glucuronopyranosyl, respectively. The location of two glycosyl
moieties were determined by the HMBC correlations (Fig. 2)
betweenH-100 (dH 4.59) and C-6 (dC 110.0), C-5 (dC 160.4), and C-7(dC 166.9), as well as between H-1000 (dH 4.48), and C-200 (dC 75.0).
Therefore, compound 1 was identified as luteolin 6-C-b-D-
glucuronopyranosyl-(1/2)-b-D-glucopyranoside.
3.3. NMR analysis of the rotamers of swertiajaponin (3)
and swertisin (6)
Swertiajaponin (3) and swertisin (6) are both 6-C-glucosyl-
flavones with 7-methoxyl group. As Table 1 shows, two sets of
signals appeared in their 1H- and 13C NMR spectra of 3 and 6,
and their intensities are approximately 9:8 in DMSO-d6. The
interconversion of two conformations were also examined to
run both 1H and 13C at 0C in d-methanol, which exhibited
more significant changes in their chemical shifts at H-3 andH-
8, and with an intensities ratios at about 4:3. Davoust et al [9]
and Rayyan et al [11] indicated that rotamers of flavonoid 6-C-
glucoside resulted in the steric hindrance from the ortho
methoxyl substituent at C-7 which restricted rotation around
the C(sp3)-C(sp2) glucosyl-flavone linkage (C-6-C-100).
3.4. HPLC and UPLC chromatograms of flavones in LHs
The optimal chromatographic condition was obtained from
different mobile phases on an Ascentis C18 HPLC column
(250mm 4.6mm, 5 mm; Supelco Analytical) for HPLC, and on
a Waters ACQUITY UPLC BECH C18, 1.7 mm at 350 nm,
respectively. As shown in Fig. 3, the flavonoid profile can be
well separated under the current HPLC (I), and UPLC (II), con-
ditions. Quercitrin was used as an I.S. to monitor the repro-
ducibility andminimize the artificial error, which exhibited an
excellent separation from all analytes. HPLC analysis was
used for the following quantitativemeasurement of fivemajor
components, 1e4, and 8.
3.5. Method validation
3.5.1. Calibration curves
A stock solution was diluted with aqueous methanol to
appropriate concentrations for establishing the calibration
curves. Five concentrations of each analyte solution were
analyzed in triplicate, respectively. The calibration curves
were then constructed by plotting the peak area versus con-
centration for each analyte. As Table 2 shows, the calibration
curves of five major compounds exhibited good linear re-
gressions over the wide concentration range of 10e500 mg/mL
of 1 and 3 with 0.9998 and 0.9995 of R2, respectively, over the
concentration range of 5e500 mg/mL of 2with 0.9998 of R2, and
the concentration range of 4e100 mg/mL of 4 and 8with 0.9993
and 0.9996 of R2, respectively, with the limit of detection at
1.0 mg/mL. The limits of quantitation of compounds 1e4 and 8
were between 4.0 mg/mL and 10.0 mg/mL (Table 2).
3.5.2. Precision and accuracy
The precision of the method was evaluated by a freshly pre-
pared standard solution in triplicate within 1 day (intraday),
and 3 consecutive days (interday), respectively. The results in
Table 2 showed that theHPLCmethod for compounds 1e4 and
8 had good reproducibility of 2.54%, 2.25%, 1.74%, 1.17%, and
0.61% of RSD, and precision with 1.48%, 1.10%, 2.35%, 2.00%,
and 4.91% of RSD, respectively.
Fig. 3 e (I) High performance liquid chromatography (HPLC) chromatogram of mixed standards (A) and commercially
available Lophatheri Herba (LHs) (BeK); 1:luteolin 6-C-b-D-glucuronopyranosyl-(1/2)-b-D-glucopyranoside; 2: isoorientin;
3:swertiajaponin; 4: luteolin 6-C-b-D-glucuronopyranosyl-(1/2)-a-L-arabinopyranoside; 5: isovitexin; 6:swertisin; 7:
luteolin 7-O-b-D-glucopyranoside; 8: luteolin 6-C-a-L-arabinopyranoside; I.S.: quercitrin. (II) Ultra performance liquid
chromatography (UPLC) chromatogram of commercially available LHs (BeK).
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Table 3 e The contents of compounds 1e4 and 8 in 10 commercial available LHs in Taiwan.
Samples Dried weight* (%)
1 2 3 4 8
B 1.170 ± 0.021 0.296 ± 0.010 1.385 ± 0.075 0.166 ± 0.016 0.126 ± 0.001
C 0.262 ± 0.018 0.074 ± 0.001 0.132 ± 0.019 0.090 ± 0.000 0.037 ± 0.000
D 0.469 ± 0.026 0.109 ± 0.010 ND 0.073 ± 0.005 0.049 ± 0.000
E 0.146 ± 0.014 0.051 ± 0.002 ND 0.045 ± 0.002 0.031 ± 0.000
F 0.268 ± 0.012 0.079 ± 0.004 0.124 ± 0.020 0.115 ± 0.005 0.061 ± 0.003
G 0.263 ± 0.012 0.070 ± 0.000 0.177 ± 0.014 0.057 ± 0.005 0.032 ± 0.002
H 0.286 ± 0.016 0.078 ± 0.002 ND 0.160 ± 0.000 0.055 ± 0.000
I 0.429 ± 0.016 0.100 ± 0.004 0.107 ± 0.013 0.136 ± 0.002 0.045 ± 0.000
J 0.286 ± 0.014 0.076 ± 0.004 ND 0.119 ± 0.003 0.044 ± 0.000
K 0.496 ± 0.043 0.132 ± 0.007 0.244 ± 0.022 0.199 ± 0.003 0.060 ± 0.003
*The values are expressed as mean ± standard deviation of triplicate tests.
LH ¼ Lophatheri Herba; ND ¼ not detected.
Table 2 e Linear regression and precision data of compounds 1e4 and 8.
Compd Linear regression
calibration curves
R2 Linear
range (mg/mL)
LOD
(mg/mL)
LOQ
(mg/mL)
Precision Intraday
RSD (%)
Interday
RSD (%)
Reproducibility
RSD (%)
1 y ¼ 10325x15222 0.9998 10e500 1.0 10.0 1.48 3.26 2.54
2 y ¼ 20479x27875 0.9998 5e500 1.0 5.0 1.10 2.65 2.25
3 y ¼ 7416.8x25846 0.9995 10e500 1.0 10.0 2.35 1.45 1.74
4 y ¼ 9621.9x21155 0.9993 4e100 1.0 4.0 2.00 1.12 1.17
8 y ¼ 14710x22613 0.9996 4e100 1.0 4.0 4.91 1.67 0.61
LOD ¼ limit of detection; LOQ ¼ limit of quantitation; RSD ¼ relative standard deviation.
Table 1 e 1H and13C nucleic magnetic resonance (NMR) data of 3 and 6 rotatmers (in DMSO-d6, 500 MHz and 125 MHz).
No. 3a 3b 6a 6b
dH dC dH dC dH dC dH dC
2 164.4 s 164.5 s 163.8 s 163.8 s
3 6.47 s 103.3 d 6.66 s 103.6 d 6.83 s 103.1 d 6.82 s 103.1 d
4 182.6 s 182.3 s 182.3 s 181.9 s
5 160.8 s 160.1 s 160.3 s 159.6 s
6 110.1 s 110.2 s 109.7 s 109.7 s
7 164.2 s 165.4 s 163.9 s 165.0 s
8 6.78 s 90.5 d 6.77 s 91.4 d 6.85 s 90.2 d 6.86 s 91.0 d
9 157.3 s 157.2 s 156.7 s 156.8 s
10 105.1 s 104.6 s 104.6 s 104.1 s
10 121.8 s 121.8 s 121.0 s 121.0 s
20 7.39 d (2.0) 113.8 d 7.39 d (2.0) 114.0 d 7.97 d (8.8) 128.5 d 7.97 d (8.8) 128.5 d
30 146.3 s 146.3 s 6.93 d (8.8) 116.0 d 6.93 d (8.8) 116.0 d
40 150.1 s 150.3 s 161.3 s 161.3 s
50 6.89 d (8.4) 116.5 d 6.89 d (8.4) 116.5 d 6.93 d (8.8) 116.0 d 6.93 d (8.8) 116.0 d
60 7.47 dd (8.4, 2.0) 119.5 d 7.47 dd (8.4,2.0) 119.5 d 7.97 d (8.8) 128.5 d 7.97 d (8.8) 128.5 d
100 4.56 d (9.6) 73.5 d 4.59 d (9.6) 73.5 d 4.59 d (9.0) 72.8 d 4.56 d (9.0) 72.6 d
200 4.17 t (9.6) 70.1 d 4.09 t (9.6) 70.7 d 4.19 m 69.6 d 3.99 m 70.3 d
300 3.15 m 79.6 d 3.19 m 79.6 d 3.06 m 79.0 d 3.06 m 79.1 d
400 3.07 m 71.4 d 3.07 m 71.4 d 3.01 m 70.8 d 3.01 m 70.9 d
500 3.14 m 82.2 d 3.14 m 82.4 d 3.05 m 81.7 d 3.05 m 81.9 d
600 3.34 dd (11.5,4.6)
3.69 dd (11.5,2.1)
62.2 t 3.34 dd (11.5,4.6)
3.69 dd (11.5,2.1)
62.2 t 3.66 dd (11.4, 5.4) 61.7 t 3.66 dd (11.4, 5.4) 61.7 t
OH 13.50 br s 13.48 br s 10.38 br s
13.48 br s
10.38 br s
13.46 br s
OCH3 3.89 s 57.0 q 3.86 s 56.7 q 3.90s 56.5 q 3.89 s 56.3 t
j o u rn a l o f f o o d a nd d r u g an a l y s i s 2 3 ( 2 0 1 5 ) 8 2 1e8 2 7826
j o u r n a l o f f o o d and d ru g an a l y s i s 2 3 ( 2 0 1 5 ) 8 2 1e8 2 7 8273.5.3. Content of flavones 1e4 and 8 in LHs
The developed HPLC method was subsequently applied to the
simultaneous determination of the flavones profile, and the
quantitative analysis of the top three major flavone C-glyco-
sides in 10 commercially available LHs. Representative chro-
matograms are shown in Fig. 3 (I), aswell as a UPLC in Fig. 3 (II).
A quantitation of five major compounds in 10 LHs by HPLC are
shown in Table 3. Their contents are 1: 0.146e1.170%; 2:
0.051e0.296%; 3: ND (not detected)e1.385%; 4: 0.045e0.199%;
8: 0.031e0.126% of dried herbal materials.4. Conclusion
In this study, a new flavone C-glycoside was isolated and
identified as luteolin 6-C-b-D-glucuronopyranosyl-(1/2)-b-D-
glucopyranoside (1), which was also measured as one of the
major components in LH. Two rotamer pairs of swertiajaponin
(3) and swertisin (6) were also found in LH for the first time and
assigned by their 1D and 2D NMR spectra. A developed HPLC
analysis with good accuracy and reproducibility was used for
simultaneous and quantitative determination of a series of
flavonoid glycosides in the LHs. The UPLC, with excellent sep-
aration quality, was compared to traditional HPLC, which is
also provided for relative time and solvent reduction. These
methods are readily accessible for the quality control of LH.Conflicts of interest
The authors declare no conflicts of interest.
Acknowledgments
The work was supported by the National Research Institute of
Chinese Medicine, Ministry of Health and Welfare, Taipei,
Taiwan (MM10211-0153).r e f e r e n c e s
[1] Ziao CC, Xiao PG. Encyclopedia of medicinal plants, Vol. 2.
Shanghai: World Publishing Corporation; 2009. p. 56e8.
[2] Zhang J, Wang Y, Zhang XQ, Zhang QW, Ye WC. Chemical
constituents from the leaves of Lophatherum gracile. Chin J
Nat Med (Zhongguo Tianran Yaowu) 2009;7:428e31.
[3] Wang Y, Chen M, Zhang J, Zhang XL, Huang XJ, Wu X,
Zhang QW, Li YL, Ye WC. Flavone C-glycosides from the
leaves of Lophatherum gracile and their in vitro antiviral
activity. Planta Med 2012;78:46e51.
[4] Shao Y, Wu QN, Tang Y, Chen R. Simultaneous quantitative
determination of seven polyphenol constituents from Herba
Lophatheri by high performance liquid chromatography.
Instrum Sci Technol 2011;39:419e31.
[5] Yuan K, Xue YQ, Yin MW, Lou LH. Simultaneous
determination of four glycosylflavones from Lophatherum
gracile by RP-HPLC. China J Chin Mat Med 2008;33:2215e8.
[6] Liu TY, Lu YH, Wei DZ, Zhou WY. Simultaneous
determination of total flavonoids and three flavonoid
glycosides in Lophatherum gracile Brongn by HPLC. Chin Trad
Pat Med 2009;31:96e100.
[7] Chinese Pharmacopoeia Commission. The pharmacopoeia of
the People's Republic of China. Beijing; Chinese Medical
Science & Technology Press: 2010 ed., vol 1, p. 308.
[8] Department of Health. Hong Kong Chinese Materia Medica
Standards, Hong Kong Special Administrative Region, Hong
Kong, 2012 ed., vol. V, pp. 220e230.
[9] Davoust D, Massias M, Molho D. 13C NMR investigation of
flavonoid C-b-D-glucosides. Detection of a conformational
equilibrium. Org Mag Res 1980;13:218e9.
[10] Sun J, Yue YD, Tang F, Guo XF. Flavonoids from the leaves of
Bambusa pervariabilis McClure. J Chil Chem Soc
2010;55:363e5.
[11] Rayyan S, Fossen T, Nateland HS, Andersen QM. Isolation
and identification of flavonoids, including flavones rotamers,
from the herbal drug 00Crataegi Folium cum Flore00
(Hawthorn). Phytochem Anal 2005;16:334e41.
